Report overview
Cancer screening aims to detect cancer before symptoms appear. This may involve blood tests, urine tests, DNA tests other tests, or medical imaging. The benefits of screening in terms of cancer prevention, early detection and subsequent treatment must be weighed against any harms.
This report contains market size and forecasts of Mobile Cancer Screening Devices in global, including the following market information:
Global Mobile Cancer Screening Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Mobile Cancer Screening Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Mobile Cancer Screening Devices companies in 2021 (%)
The global Mobile Cancer Screening Devices market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cervical Cancer Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Mobile Cancer Screening Devices include AbDent, Inc., Apteryx, Inc., Breastlight, Braster S.A., Bremed Ltd., Forward Science, MobileODT Ltd., Niramai Health Analytix and TruScreen and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Mobile Cancer Screening Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mobile Cancer Screening Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Mobile Cancer Screening Devices Market Segment Percentages, by Type, 2021 (%)
Cervical Cancer
Breast Cancer
Oral Cancer
Others
Global Mobile Cancer Screening Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Mobile Cancer Screening Devices Market Segment Percentages, by Application, 2021 (%)
Home Care Settings
Specialty Clinics
Hospitals
Global Mobile Cancer Screening Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Mobile Cancer Screening Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Mobile Cancer Screening Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Mobile Cancer Screening Devices revenues share in global market, 2021 (%)
Key companies Mobile Cancer Screening Devices sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Mobile Cancer Screening Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbDent, Inc.
Apteryx, Inc.
Breastlight
Braster S.A.
Bremed Ltd.
Forward Science
MobileODT Ltd.
Niramai Health Analytix
TruScreen
UE LifeSciences
